Srpt Stock close

BMO Capital Cuts Sarepta Therapeutic (SRPT) PT to $25 from $50
Tuesday, 29 July 2025 05:50   Yahoo Financearrow_outward

10 Most Undervalued Stocks to Buy and Hold for 3 Years
Tuesday, 29 July 2025 05:50   Insider Monkeyarrow_outward

$SRPT stock is up 8% today. Here's what we see in our data.
Tuesday, 29 July 2025 05:50   Quiver Quantitativearrow_outward

(SRPT) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Tuesday, 29 July 2025 00:28   News.stocktradersdaily.comarrow_outward

Sarepta Therapeutics (SRPT) Gains Rare Bid Today Despite Latest Analyst Cut - AskTraders.com
Monday, 28 July 2025 22:53   AskTraders.comarrow_outward

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Monday, 28 July 2025 20:01   GlobeNewswirearrow_outward

Sarepta Therapeutics: Beaten Down, But Not Out (NASDAQ:SRPT) - Seeking Alpha
Monday, 28 July 2025 16:17   Seeking Alphaarrow_outward

SRPT STOCK REMINDER: BFA Law Reminds Sarepta Therapeutics, Inc. Investors with Losses to Contact the Firm by August 25 Legal Deadline - Newsfile
Sunday, 27 July 2025 19:36   Newsfilearrow_outward

Sarepta Addresses FDA Investigation: ELEVIDYS Gene Therapy Death Ruled Unrelated to Treatment - Stock Titan
Saturday, 26 July 2025 07:51   Stock Titanarrow_outward

Sarepta Therapeutics' Brutal Week Continues With Bad News Out Of Europe - Investor's Business Daily
Saturday, 26 July 2025 04:12   Investor's Business Dailyarrow_outward

Sarepta (SRPT) Faces Setback with Elevidys Amid Regulatory Challenges | SRPT Stock News - GuruFocus
Friday, 25 July 2025 23:45   GuruFocusarrow_outward

Does SRPT stock pay reliable dividends - Accelerated capital growth - jammulinksnews.com
Friday, 25 July 2025 20:23   Jammulinksnews.comarrow_outward

SRPT Stock Analysis and Forecast - Superior trading gains - Autocar Professional
Friday, 25 July 2025 08:59   Autocar Professionalarrow_outward

September 5th Options Now Available For Sarepta Therapeutics (SRPT) - Nasdaq
Thursday, 24 July 2025 22:56   Nasdaqarrow_outward

Is This Stock a Buy After Soaring by 20% in 1 Day? - The Motley Fool
Thursday, 24 July 2025 19:40   The Motley Foolarrow_outward

Citi Opens 90d Downside Catalyst Watch on Sarepta Therapeutics (SRPT) - StreetInsider
Thursday, 24 July 2025 18:49   StreetInsiderarrow_outward

Sarepta Faces FDA Hold on Gene Therapy Trials - The Globe and Mail
Tuesday, 22 July 2025 20:40   The Globe and Mailarrow_outward

Sarepta (SRPT) stock just set the worst precedent in biotech history - Investorsobserver
Tuesday, 22 July 2025 14:48   Investorsobserverarrow_outward

Sarepta Worth $0 Amid ‘Unwinnable’ FDA Fight, HC Wainwright Says - Bloomberg
Tuesday, 22 July 2025 04:13   Bloombergarrow_outward

SRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline Pivots - MSN
Friday, 18 July 2025 20:22   MSNarrow_outward

SRPT Stock Soars on Unveiling New Restructuring Plan, Pipeline Pivots - Zacks Investment Research
Thursday, 17 July 2025 22:02   Zacks Investment Researcharrow_outward

Stocks making the biggest moves after hours: United Airlines, Sarepta Therapeutics and more - CNBC
Wednesday, 16 July 2025 15:00   CNBCarrow_outward

Oppenheimer cuts Sarepta price target on liver failure death concerns - Investing.com
Friday, 20 June 2025 15:00   Investing.comarrow_outward

Sarepta Stock (SRPT) Could Soar 200% Despite Growing Caution on Wall Street - TipRanks
Wednesday, 18 June 2025 15:00   TipRanksarrow_outward

SRPT Stock: What’s Happening With Sarepta Therapeutics? - Forbes
Tuesday, 17 June 2025 15:00   Forbesarrow_outward

From $172 to $20: Sarepta’s Spectacular Fall - Trefis
Tuesday, 17 June 2025 15:00   Trefisarrow_outward